Announcing a new article publication for Cardiovascular Innovations and Applications journal. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are approved for heart failure with reduced ejection fraction (HFrEF).
Health Groups Have High Hopes for the Latest Prior Authorization Bill
Medical groups are optimistic that a recently reintroduced bill to rein in prior authorization has a better chance of passage now than it did last